Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Rapid Micro Biosystems (RPID) Other financing activities (2020 - 2021)

Rapid Micro Biosystems' Other financing activities history spans 2 years, with the latest figure at $1.5 million for Q2 2021.

On a quarterly basis, Other financing activities rose 496.11% to $1.5 million in Q2 2021 year-over-year; TTM through Dec 2025 was $4.2 million, a 0.42% change, with the full-year FY2025 number at $878000.0, changed N/A from a year prior.
Other financing activities hit $1.5 million in Q2 2021 for Rapid Micro Biosystems, down from $2.7 million in the prior quarter.
Over the last five years, Other financing activities for RPID hit a ceiling of $2.7 million in Q1 2021 and a floor of $18000.0 in Q4 2020.